News

Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...
Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.
A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...
The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.
Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.
The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.
Starting in 2025,a pricing model aims to make novel therapies more accessible to sickle cell patients in the US with limited resources.
The blood-separation device Spectra Optia, which has the ability to remove abnormal red blood cells from sickle cell patients, can efficiently and safely replace these cells with healthy red blood ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
This high rate of readmissions was associated with a significant financial burden on the healthcare system, the researchers said in the study, titled “ Epidemiology and Predictors of all-cause 30-Day ...
Columnist Tito Oye notes the importance of staying hydrated for those with sickle cell anemia and shares tips on how to maintain sufficient water intake.